| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0006 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |